Overview

Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to find a clinically appropriate dose of PAC-14028 cream by comparatively evaluating the efficacy and safety of PAC-14028 cream of Amorepacific Corporation in patients with dermal pruritus.
Phase:
Phase 2
Details
Lead Sponsor:
Amorepacific Corporation